Literature DB >> 3479529

Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: longitudinal confirmation.

J V Haxby1, C L Grady, R P Friedland, S I Rapoport.   

Abstract

Patterns or regional cerebral metabolism and neuropsychological function were studied longitudinally in 10 mildly demented patients with dementia of the Alzheimer type (DAT) and compared to those of moderately demented patients and controls. As reported previously (Haxby et al., 1986), the mildly demented patients initially had significant neocortical metabolic abnormalities, namely parietal reductions and right-left asymmetries, but did not differ from controls on any test of neocortically-mediated visuospatial and language functions. Right-left metabolic asymmetries correlated with neuropsychological discrepancies between visuospatial and language function in moderately demented but not mildly demented patients. We now report that longitudinal studies of these mildly demented patients showed significant decline of nonmemory cognitive function. Moreover, correlations of metabolic asymmetries with neuropsychological discrepancies between visuospatial and language functions became significant. These longitudinal results confirm our previous conclusion that neocortical metabolic abnormalities precede neocortically-mediated neuropsychological impairments in early DAT.

Entities:  

Mesh:

Year:  1987        PMID: 3479529

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  6 in total

1.  Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

Authors:  U M Mann; E Mohr; M Gearing; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Mapping the Progression of Atrophy in Early- and Late-Onset Alzheimer's Disease.

Authors:  Raffaella Migliaccio; Federica Agosta; Katherine L Possin; Elisa Canu; Massimo Filippi; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Diabetes, insulin resistance, and dementia among HIV-1-infected patients.

Authors:  Victor G Valcour; Cecilia M Shikuma; Bruce T Shiramizu; Andrew E Williams; Michael R Watters; Pamela W Poff; John S Grove; Ola A Selnes; Ned C Sacktor
Journal:  J Acquir Immune Defic Syndr       Date:  2005-01-01       Impact factor: 3.731

Review 4.  Clinical Insights into Mitochondrial Neurodevelopmental and Neurodegenerative Disorders: Their Biosignatures from Mass Spectrometry-Based Metabolomics.

Authors:  Haorong Li; Martine Uittenbogaard; Ling Hao; Anne Chiaramello
Journal:  Metabolites       Date:  2021-04-10

5.  Transcranial Direct Current Stimulation Modulates Cortical Neuronal Activity in Alzheimer's Disease.

Authors:  Sara Marceglia; Simona Mrakic-Sposta; Manuela Rosa; Roberta Ferrucci; Francesca Mameli; Maurizio Vergari; Mattia Arlotti; Fabiana Ruggiero; Elio Scarpini; Daniela Galimberti; Sergio Barbieri; Alberto Priori
Journal:  Front Neurosci       Date:  2016-03-31       Impact factor: 4.677

6.  Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease.

Authors:  Laure Saint-Aubert; Ove Almkvist; Konstantinos Chiotis; Rita Almeida; Anders Wall; Agneta Nordberg
Journal:  Alzheimers Res Ther       Date:  2016-09-29       Impact factor: 6.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.